Status:
RECRUITING
Pilot Study Evaluating the Impact of Stress Reduction on Atherosclerotic : Heart and Mind Study
Lead Sponsor:
Massachusetts General Hospital
Conditions:
Atherosclerosis
Stress
Eligibility:
All Genders
30-65 years
Phase:
NA
Brief Summary
The plot study aims to evaluate the effect of 8 weeks of stress reducing intervention on atherosclerotic plaque inflammation in adults, as quantified by positron emission tomography (PET) with fluorin...
Detailed Description
This randomized controlled imaging study will be performed to evaluate the impact of mindfulness-based stress reduction via a mind body program on arterial inflammation in individuals with self-identi...
Eligibility Criteria
Inclusion
- • Aged between 30-65 years
- Identifies as having increased levels of stress and/or has a Perceived Stress Scale (PSS) score \>5 at baseline, and is interested in participating
Exclusion
- Perceived Stress Scale (PSS) score \<6
Key Trial Info
Start Date :
September 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 30 2026
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04496947
Start Date
September 1 2018
End Date
December 30 2026
Last Update
December 26 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Massachusetts General Hospital
Boston, Massachusetts, United States, 02114